Efficacy and safety of VENCLEXTA in the treatment of CLL and AML
Loading Map....
You are cordially invited to attend a clinical presentation about the efficacy and safety of VENCLEXTA in the treatment of CLL and AML
Speaker:
Yair Levy, M.D. – Director Hematologic Malignancies Research, Baylor University Medical Center, Dallas TX; Associate in Hematology TOPA, Baylor University Medical Center Dallas, TX; Assistant Professor of Medicine, Texas A&M HSC College of Medicine, Texas Oncology-Baylor Charles A. Sammons Cancer Center
RSVP By July 30, 2021
To Sharon McCarthy (650) 388-2369 sharon.mccarthy@abbvie.com
Or RSVP Online: